(MEDICAL NEWS TODAY) — Scientists have developed a new vaccine that — in conjunction with existing therapies — can not only treat aggressive melanoma, but also prevent its recurrence.

Researchers from the Scripps Research Institute in San Diego, CA, recently worked with experts from other institutions to develop a vaccine that would be effective against melanoma (a type of skin cancer) when administered in conjunction with other therapies.

According to Prof. Dale Boger, who co-led the research with Nobel laureate Bruce Beutler, “This co-therapy produced a complete response — a curative response — in the treatment of melanoma.”